Arun Goel

faculty photo

Arun Goel, MD

Assistant Professor of Clinical Radiation Oncology
Department: Radiation Oncology

Contact information
3400 Civic Center Blvd.
Perelman Center for Advanced Medicine
Philadelphia, PA 19104
Education:
BA (Biology Modified with Chemistry)
Dartmouth College, 2009.
MD (Doctorate of Medicine)
Drexel University College of Medicine, 2014.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

HDR Brachytherapy
HDR Prostate Brachytherapy
HDR Gynecologic Brachytherapy
Prostate SBRT
Ultrasound-based HDR Brachytherapy

Selected Publications

Nishant K. Shah , MD1; Kristine N. Kim , MD1; Amardeep Grewal, MD1; Xingmei Wang, MS1; Edgar Ben-Josef, MD1; John P. Plastaras , MD, PhD1; James M. Metz, MD1; Arun Goel, MD1; Neil K. Taunk , MD, MSCTS1; Jacob E. Shabason , MD, MTR1; John N. Lukens, MD1; Abigail T. Berman, MD, MSCE1; and Andrzej P. Wojcieszynski , MD1: Activity Monitoring for Toxicity Detection and Management in Patients Undergoing Chemoradiation for Gastrointestinal Malignancies. JCO Oncology Practice 18(6), June 2022.

Manuj Agarwal MD, Christopher Wright MD, Shweta Manjunath MD, Arun Goel MD: Dose Escalation for High-Risk Prostate Cancer: Brachytherapy versus Stereotactic Body Radiotherapy Boost. ABS BrachyBlast NewsLetter February 2022.

Gorovets D., Hopkins M., Kollmeier M., Moore A., Goel A., Shasha D., Brennan V., McBride S., Cohen G., Damato A., Zelefsky MJ.: High-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer. Brachytherapy 2021.

Harandi NK, Goel A, Huang AJ, Huang KE, Abendroth RA, Lee JW, Kashani-Sabet M, Kim KB: Outcomes for advanced melanoma with brain metastases treated with stereotactic radiosurgery (SRS) with and without PDL1 therapy American Society for Radiation Oncology Annual Meeting, San Antonio, TX 2018 Notes: poster.

Arun Goel MD, Chi-Mei Liu Ph.D, Praneet Kaur, Michael L. Wong MD, Lawrence M. Scala MD: Genitourinary Toxicity in patients with Intermediate and High Risk Prostate Cancer managed with Hypofractionated Radiation and HDR Brachytherapy Boost. American Society for Radiation Oncology Annual Meeting, San Antonio, TX 2018 Notes: e-poster

Huang AJ, Huang KE, Kumar RJ, Goel A, Harandi NK, Birer SR, Rounsaville MC, Lee JW, Abendroth R: Two-Fraction Radiosurgery (9Gy x 2) is an effective and safe option in the Modern Era of CNS-Penetrating Systemic Therapies Radiological Society of North America Annual Meeting, Chicago, IL 2018 Notes: oral.

Huang AJ, Huang KE, Kumar RJ, Goel A, Harandi NK, Rounsaville MC, Abendroth RE, Lee JW: Dose-Reduced Stereotactic Radiosurgery for Brain Metastases in the Era of CNS-Penetrating Systemic Therapies American Society for Radiation Oncology Annual Meeting, San Antonio, TX 2018 Notes: poster.

Huang AJ, Huang KE, Goel A, Kumar RJ, Linam JL, Lee JW: Advances in Healthcare Accessibility and Imaging Technology Have Led to Shifts in the Proportion of Early and Late Stage Pediatric Cancers: An Analysis of the 1994-2013 SEER Registries International Journal of Radiation Oncology * Biology * Physics 2017 Oct; 99(2S):S2949. American Society for Radiation Oncology Annual Meeting, San Diego, CA 2017 Notes: poster.

Kumar RJ, Aneja S, Chan D, Goel A, Huang A, Harandi NK, Lee J: Clinical Risk Factors Associated with Improved Relative Survival Among Metastatic Breast Cancer Patients Receiving Palliative Radiation Therapy Radiological Society of North American Annual Meeting, Chicago, IL 2017 Notes: oral.

Kumar RJ, Goel A, Chan D, Heal C, Huang AJ, Lee JW: Intraoperative Radiation Therapy Versus Hypofractionated Whole Breast Irradiation in T1N0, ER Positive Patients. International Journal of Radiation Oncology * Biology * Physics. 2017 Oct; 99(2S): S2062 American Society for Radiation Oncology Annual Meeting, San Diego, CA 2017 Notes: poster.

back to top
Last updated: 09/13/2023
The Trustees of the University of Pennsylvania